Rang	Name	Position
1	Mr. Chad M. Robins M.B.A.	Co-Founder, CEO & Chairman
2	Ms. Julie Rubinstein	President & COO
3	Mr. Kyle Piskel	VP, CFO & Principal Accounting Officer
4	Ms. Susan Bobulsky	Chief Commercial Officer of MRD
5	Mr. Christopher Carlson Ph.D.	Founder
6	Ms. Karina Calzadilla	VP of Investor Relations and FP&A
7	Ms. Clarice McCauley	Head of Legal, Corporate Secretary, VP & Chief Compliance Officer
8	Mr. Francis T. Lo	Chief People Officer
9	Dr. Sharon Benzeno Ph.D.	Chief Commercial Officer of Immune Medicine
10	Ms. Mary Pat Lancelotta	Senior Vice President of MRD BioPharma

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Viking Global Investors LP	4,70%	0,18 Mrd. USD
2	BlackRock Inc	2,08%	0,08 Mrd. USD
3	Vanguard Capital Management, LLC	0,95%	0,04 Mrd. USD
4	Wellington Management Company LLP	0,93%	0,04 Mrd. USD
5	D. E. Shaw & Co LP	0,72%	0,03 Mrd. USD
6	Vanguard Portfolio Management, LLC	0,70%	0,03 Mrd. USD
7	Amvescap Plc.	0,70%	0,03 Mrd. USD
8	Westfield Capital Management Company, L.P.	0,67%	0,03 Mrd. USD
9	Geode Capital Management, LLC	0,57%	0,02 Mrd. USD
10	Lord, Abbett & Co LLC	0,55%	0,02 Mrd. USD
11	The Goldman Sachs Group Inc	0,51%	0,02 Mrd. USD
12	State Street Corp	0,51%	0,02 Mrd. USD
13	Ameriprise Financial Inc	0,47%	0,02 Mrd. USD
14	BNP Paribas Investment Partners SA	0,42%	0,02 Mrd. USD
15	ARK Investment Management LLC	0,33%	0,01 Mrd. USD
16	Fred Alger Management, LLC	0,32%	0,01 Mrd. USD
17	Arrowstreet Capital Limited Partnership	0,31%	0,01 Mrd. USD
18	Delaware Management Holdings Inc	0,29%	0,01 Mrd. USD
19	Driehaus Capital Management LLC	0,27%	0,01 Mrd. USD
20	Aristotle Atlantic Partners, LLC	0,27%	0,01 Mrd. USD